D-0411-2025 Class II Ongoing
FDA drug recall D-0411-2025 was initiated by RemedyRePack Inc. on Apr 22, 2025 and is designated Class II. Reason for recall: CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets. The recall status is ongoing. Affected quantity: 23 bottles/30 count- 690 capsules.
Recall details
- Product Type
- Drugs
- Report Date
- May 14, 2025
- Initiation Date
- Apr 22, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23 bottles/30 count- 690 capsules
Product description
Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02
Reason for recall
CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Distribution pattern
Within U.S - PA, VA, FL.
Code information
Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0411-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026